At present, it is the 20 12 version of essential drugs. Compared with the 2009 edition, the number of varieties has been increased, the catalogue structure has been optimized, and varieties and dosage forms suitable for special people have been increased. This is a concrete practice of fully implementing the spirit of the 18th CPC National Congress, which is conducive to further deepening medical reform and consolidating the basic drug system. It is conducive to deepening the reform of public hospitals and promoting the interconnection of medical insurance, medicine and medical care; It is conducive to ensuring the basic, strengthening the grassroots and building mechanisms; Conducive to the prevention and treatment of common diseases, frequently-occurring diseases and chronic diseases, especially major diseases; It is conducive to reducing the burden of people's medication and meeting the basic medication; It is conducive to establishing a correct orientation and promoting the optimization and upgrading of pharmaceutical enterprises; Is conducive to promoting medical science and technology innovation.
The 20 12 catalogue is divided into three parts: chemical and biological products, Chinese patent medicines and Chinese herbal pieces, of which 3 17 are chemical and biological products, 203 are Chinese patent medicines and 520 are Chinese patent medicines. The 20 12 version of the catalogue has the following characteristics: first, it has increased the number of varieties, which can better serve primary medical and health institutions and promote medical and health institutions at all levels to fully equip and give priority to the use of essential drugs. The second is to optimize the structure, supplement the categories of anti-tumor and hematological drugs, and pay attention to the connection with common diseases, frequently-occurring diseases, especially major diseases, and maternal and child drugs. The third is to standardize dosage forms and specifications, and initially achieve standardization. 520 kinds of drugs involve more than 850 dosage forms and specifications of 1400. Although the number of varieties in the catalogue has increased, compared with 307 varieties in the catalogue in 2009, the number has obviously decreased, which will be of great significance for guiding the production and circulation of essential drugs, bidding and procurement, rational drug use, pricing reimbursement and whole process supervision.
The 20 12 edition of the Catalogue pays full attention to the effective connection with other policies. First, pay attention to the connection with the World Health Organization model list of essential drugs. The number of chemicals and biological products is close to the number of essential drugs recommended by the World Health Organization, which better represents the level of developing countries. The second is to pay attention to the connection with the payment ability of medical insurance (new rural cooperative medical system) to ensure a high proportion of reimbursement of essential drugs. Third, pay attention to the connection with common diseases and frequently-occurring diseases, as well as the use of drugs by women and children, and continue to pay equal attention to Chinese and western medicine. Fourth, we should pay attention to the connection with ensuring the use of drugs for major diseases. The catalogue contains drugs for the treatment of childhood leukemia, end-stage renal disease, hemophilia and other major diseases, which basically meet the clinical basic drug demand for major diseases.